HomeCYAD • EBR
add
Celyad Oncology SA
Previous close
€0.21
Day range
€0.20 - €0.21
Year range
€0.20 - €1.22
Market cap
8.44M EUR
Avg Volume
38.15K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 7.00K | 0.00% |
Operating expense | 1.83M | 18.48% |
Net income | -1.84M | -20.73% |
Net profit margin | -26.25K | -20.73% |
Earnings per share | — | — |
EBITDA | -1.72M | -20.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 790.00K | -87.32% |
Total assets | 5.70M | -55.64% |
Total liabilities | 8.80M | -8.16% |
Total equity | -3.10M | — |
Shares outstanding | 41.43M | — |
Price to book | -3.00 | — |
Return on assets | -80.16% | — |
Return on capital | 201.21% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.84M | -20.73% |
Cash from operations | -1.64M | -15.65% |
Cash from investing | — | — |
Cash from financing | -68.00K | -106.25% |
Net change in cash | -1.70M | -340.00% |
Free cash flow | -1.02M | -10.62% |
About
Founded
2004
Headquarters
Website
Employees
18
